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Introduction
Cancer is the leading causes of death in whole the 
world. In either developing or developed countries with 
high or very high levels on the Human Development Index 
(HDI), prostate cancer (PC) explains a great part of the 
overall cancer incidence burden (Ferlay et al., 2010). PC 
is the fourth most common cancer in both sexes combined 
and the second most common cancer in men. An estimated 
1.1 million men worldwide were diagnosed with PC in 
2012, accounting for 15% of the cancers diagnosed in men. 
PC is the fifth leading cause of death from cancer in men 
(6.6% of the total men deaths) with an estimated 307,000 
deaths in 2012 (International Agency for Research on 
Cancer, 2012). PC is a disease of increasing significance 
worldwide. Incidence rates of PC have been increasing 
in almost all countries, irrespective of HDI level, with 
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Abstract
 Background: Prostate cancer (PC) is one of the leading causes of death, especially in developed countries. 
The human development index (HDI) and its dimensions seem correlated with incidence and mortality rates 
of PC. This study aimed to assess the association of the specific components of HDI (life expectancy at birth, 
education, gross national income per 1000 capita, health, and living standards) with burden indicators of PC 
worldwide. Materials and Methods: Information of the incidence and mortality rates of PC was obtained from 
the GLOBOCAN cancer project in year 2012 and data about the HDI 2013 were obtained from the World Bank 
database. The correlation between incidence, mortality rates, and the HDI parameters were assessed using 
STATA software. Results: A significant inequality of PC incidence rates was observed according to concentration 
indexes=0.25 with 95% CI (0.22, 0.34) and a negative mortality concentration index of -0.04 with 95% CI (-0.09, 
0.01) was observed. Conclusions: A positive significant correlation was detected between the incidence rates of 
PC and the HDI and its dimensions including life expectancy at birth, education, income, urbanization level and 
obesity. However, there was a negative significant correlation between the standardized mortality rates and the 
life expectancy, income and HDI. 
Keywords: Human development index - prostate cancer - correlation - GLOBOCAN cancer project
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average increases varied between 3.2% and 7% (Bray 
et al., 2012). Of course, PC incidence rates are higher in 
more developed regions because the practice of prostate 
specific antigen (PSA) testing and subsequent biopsy has 
become available for PC screening in developed countries 
and those regions have experienced a huge increase in 
PC incidence (Brawley, 2012). Almost 70% of the cases 
worldwide living in developed countries, despite such 
regions comprising only 15% of the world’s population, 
in contrast, the increase in PC mortality rates mainly 
occurred in lower resource settings (Center et al., 2012). 
Because PSA testing has a much greater effect on 
incidence than on mortality, there is less variation in 
mortality rates worldwide than is observed for incidence, 
with the number of deaths from PC larger in less developed 
than in more developed regions (International Agency for 
Research on Cancer, 2012). PC seems to be positively 
Salman Khazaei et al
Asian Pacific Journal of Cancer Prevention, Vol 17, 20163792
associated with the level of macroeconomic development 
factors. The reasons for this association are not clear and 
there are few researches examining how socioeconomic 
determinants correlate with PC incidence and mortality. 
The aim of this study is to assess the association of the 
specific components of HDI (life expectancy at birth, 
education, gross national income per 1000 capita, health, 
and living standards) with burden indicators of PC. 
We used the data of International Agency for Research 
on Cancer (IARC) that represents the most up to date 
information on the incidence of PC around the world 
(Ferlay et al., 2014).
Materials and Methods
Present ecological study used dataset regarding the 
incidence and mortality rates of PCs and some related 
health factors in the world. Data of the incidence and 
mortality rates of cancers was obtained from the global 
cancer project for 172 countries in year 2012 (Ferlay et al., 
2014). Data about the HDI 2013 and its gradient including 
life expectancy at birth, mean years of schooling, and 
gross national income (GNI) per capita and also other 
health related variables were obtained from the World 
bank database for 169 countries (Malik, 2013).
Data analysis was restricted to 169 countries that 
both the epidemiologic data from the GLOBOCAN 
database and the HDI were available. These countries 
categorized into four categories including (1) Very 
High Human Development (27 countries), (2) High 
Human Development (37 countries), (3) Medium 
Human Development (89 countries) and (4) Low Human 
Development (16 countries). We defined inequality in 
the age-specific incidence and mortality rates (ASR) 
of PCs according to the HDI by using concentration 
index. The value of concentration index is ranged from 
-1 to +1, the negative value is indicating that the health 
variable is more concentrated in the poor population and 
the positive value indicates in rich population. We also 
used linear regression models for assessment of the HDI 
effect and other variables on PC occurrence rates. Data 
were analyzed by STATA software version 12 (StataCorp, 
College Station, TX, USA).
Table 1. Concentration Indexes for Inequality of Incidence and Mortality of Prostate Cancer According to HDI
Cancer type New cases diagnosed in 2012 (1,000s)
Death form PC in 
2012 (1,000s)
Incidence 
concentration index 
(95%CI)
Mortality 
concentration index 
(95%CI)
Incidence/Mortality 
concentration index 
(95%CI)
Prostate 1,112 307 0.28 (0.22,0.34) -0.04(-0.09,0.01) 0.32(0.27,0.36)
Table 2. Effect of HDI Components And Demographic Variables on Prostate Cancer Incidence and Mortality Rates
Variables Prostate cancer incidence Prostate cancer mortalityB CI P-value B CI P-value
Life expectancy at birth 1.58 (1.12, 2.05) <0.001 -0.25 (-0.42, -0.1) 0.002
Mean years of schooling 5.7 (4.42, 6.98) <0.001 -0.19 (-0.67, 0.29) 0.44
Gross national income per 1000 capita 0.76 (0.52, 1) <0.001 -0.09 (-0.17, -0.01) 0.026
HDI 111 (85.8, 136.3) <0.001 -10.18 (-19.56, -0.8) 0.034
Urbanization level (%) 0.58 (0.4, 0.77) <0.001 -0.05 (-0.12, 0.01) 0.1
Age standardized obesity in adults 0.97 (0.54, 1.4) <0.001 0.02 (-0.12, 0.16) 0.86
Figure 1. Incidence and Mortality of Prostate Cancer 
Ranked by Human Development Index in World (2012)
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Figure 2. Incidence and Mortality of Prostate Cancer 
in Different HDI Regions in 2012 (per 100,000 pop)
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Results 
The study analyses constitute the global overview of 
the current patterns of cancer incidence and mortality in 
relation to predefined levels of HDI. Positive value of 
concentration index in Table 1 and also results from Figure 
2 for incidence of PC indicated that this cancer in more 
concentrated in High HDI countries. Negative value of 
concentration index in Table 1 and also results from Figure 
2 for death from PC indicated that this cancer in more 
concentrated in low HDI countries. The concentration 
index and %95confidence interval for incidence, mortality 
and incidence/mortality rates of PC is presented in detail 
in Table 1.
In Figure 1 also we showed the concentration index 
for incidence and mortality of PC graphically.
Linear regression model showed that increasing of 
HDI had a positive effect on increasing the incidence 
(B=111, P<0.001) and a negative effect on mortality (B=-
10.18, P=0.034) rates of PC. The mean of life expectancy 
at birth, mean years of schooling, GNI per capita, percent 
of urbanization, and age standardized obesity had also 
a positive effect on increasing in incidence rates (Table 
2). But life expectancy at birth and GNI per capita had a 
negative effect on PC mortality. 
Discussion
In this study, we used the Human Development Index 
(HDI) as an indicator of socioeconomic development, 
and PC incidence and mortality rates as markers of the 
extent of the cancer transition globally. Results showed 
PC burden estimates vary from developing to developed 
countries. The world’s populations were classified by 
broad levels of human development index. However, this 
classification is not deterministic and some countries are 
rapidly transiting from lower to higher levels of human 
development.
Results showed that the incidence rates of PC in 
developing countries may be less common, while its 
incidence and mortality has been on the rise (Ekeke et 
al., 2012). However, incidence rates are influenced by 
the intensity of diagnostic efforts. PC can be diagnosed 
from a variety of methods. Several decades ago, suspected 
patients for benign prostatic hyperplasia (BPH) were 
operated but during the pathological examination of 
specimens from transurethral prostatectomies, up to 25 
percent of cases were discovered to have PC. Another 
test is digital rectal examination (DRE), which is easy. 
Recently, PSA came into existence and the frequency 
of finding new cases of PC has precipitously increased 
(Ørsted and Bojesen, 2013). The increasing burden of 
cancer in developing countries seems to be as a result 
of increased life expectancy and may be attributed to 
a westernized diets effect and other cancer associated 
behavioral determinants including smoking, alcohol 
consumption, physical inactivity, and reproductive, 
dietary and hormonal risk factors (Bray et al., 2012).For 
example, PC is the most common cause of cancer death 
in men in several sub-Saharan African countries-both that 
contributes to both environmental and lifestyle exposures 
in these regions (Jemal et al., 2012). In low HDI level 
countries, poor access to cancer control and prevention 
and late diagnosis lead to higher mortality rates. Most 
researchers believe that the reduction in PC mortality 
rates in developed regions over the last several years is 
attributed to early detection initiatives (Baade et al., 2013). 
These findings are in accordance with national trends in 
incidence and mortality rates. There are a large numbers 
of men who diagnosed with PC in United States and 
relatively few die of the disease that suggests they may 
be either diagnosed earlier or in a more curable state of 
the disease. In contrast, the incidence rates may be lower 
in many Asian and African countries. These patients may 
be diagnosed later, with advanced stage and incurable 
diseases (Cullen et al., 2012).
Results of the linear regression model showed a 
significant association of PC incidence and mortality rates 
with HDI dimensions including life expectancy, education, 
GNI, urbanization level, and age standardized obesity. 
Life expectancy at birth is one of the dimensions of 
HDI. There is a positive association between incidence 
of PC and older ages. Almost 75% of new cancer cases 
occur in people older than 85 years (Plata and Concepcion, 
2014). Reports revealed that developed countries have 
the higher life expectancy at birth (Salomon et al., 2013) 
that is in accordance with our findings, higher incidence 
rate in more developed regions at the same countries with 
higher life expectancy, we found a significant negative 
association with PC mortality rates that is attributed to 
better cancer control facilities in developed areas.
Education and years of schooling is another dimension 
of HID that can effect on screening and early detection 
in individuals. As a result, many subclinical cases are 
detected and the incidence of the disease increases. In 
addition, in several studies, awareness was accounted as 
an important factor that influenced treatment of disease 
and the distribution of mortality from this type of cancer 
(Hassona et al., 2015; Bloodgood, 2016), but in our study, 
a significant association was not seen between education 
and PC mortality rates.
Adequate income is specified by Gross national 
income per 1000 capita which is one of HDI dimensions. 
Several studies suggest the impact of income level on 
cancer treatment. People with low incomes are more likely 
to die from PC (Decker et al., 2016). People in developed 
areas with increasing income levels and improved 
socioeconomic status have better access to diagnostic 
services and screening tests, such as PSA (Bray et al., 
2012; Morris et al., 2013).
Such results were seen in other study conducted 
for comparison of PC burden within Asian countries 
with different HDI level. It was showed that countries 
such as Israel, Turkey, Lebanon, Singapore, Japan, and 
Republic of Korea with highest life expectancy, income 
and education level in Asia had the highest incidences of 
PC (Pakzad et al., 2015).
According to other researches, as the urbanization 
level increasing, the incidence of PC is also increasing. 
This may be attributed to individuals’ lower physical 
activities in urban areas in comparison with rural areas. 
Urban residents are also more likely to consume western 
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foods with high calories and fat that is a risk factor of PC 
(Hebert et al., 2006). In accordance with our findings; 
several articles have shown an association between age 
standardized obesity in adults and the development of 
newly PC incidences (Möller et al., 2013) but we didn’t 
find any association between obesity and PC mortality 
rates.
However, the incidence and mortality rates reported 
for any geographic area depend on the reliability of cancer 
registries. There are not high quality population-based 
cancer registries in Africa, Asia, and Latin America, and 
there are few national vital registration systems with 
adequate mortality data in low resource and medium-
resource countries. The incidence and mortality estimates 
from GLOBOCAN for 2012 are also subject to precision 
limitations because a hierarchy of accuracy, quality and 
availability of the GLOBOCAN information sources at a 
given time in different countries.
In conclusion, in countries with greater development, 
the incidence of PC is higher and in lower developed 
countries, the mortality rates of the cancer are higher. 
We observed a positive significant correlation between 
the burden indicators of PC and the HDI, life expectancy 
at birth, education, and gross national income per 1000 
capita, urbanization level and obesity. However, there was 
a negative significant correlation between the standardized 
mortality rates and the life expectancy, GNI and HDI. 
Information on the incidence and mortality of PC can be 
useful for medical planning and research activities.
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